FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products ...

Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.

The plaintiffs are asking the court to declare the Gold Card program unlawful and to halt its implementation.

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

The destination? A Tennessee-based DNA analysis lab called PooPrints. The goal? To find a DNA match with a dog in the ...

When he squeezes into his bright red ski suit and puts on his Darth Vader-esque helmet, speed skier Simon Billy hears nothing ...